347 related articles for article (PubMed ID: 1690272)
1. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin.
Gershenson DM; Morris M; Cangir A; Kavanagh JJ; Stringer CA; Edwards CL; Silva EG; Wharton JT
J Clin Oncol; 1990 Apr; 8(4):715-20. PubMed ID: 1690272
[TBL] [Abstract][Full Text] [Related]
2. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
[TBL] [Abstract][Full Text] [Related]
3. Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatin.
Gershenson DM; Kavanagh JJ; Copeland LJ; Del Junco G; Cangir A; Saul PB; Stringer CA; Edwards CL; Wharton JT
Cancer; 1986 May; 57(9):1731-7. PubMed ID: 2420435
[TBL] [Abstract][Full Text] [Related]
4. Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau.
Germá JR; Izquierdo MA; Seguí MA; Climent MA; Ojeda B; Alonso C
Gynecol Oncol; 1992 May; 45(2):153-9. PubMed ID: 1375576
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
Culine S; Kattan J; Lhomme C; Duvillard P; Michel G; Castaigne D; Leclere J; Pico J; Droz JP
Gynecol Oncol; 1994 Jul; 54(1):47-53. PubMed ID: 7517380
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, vinblastine and bleomycin in advanced and relapsed germ cell tumours of ovary.
Kumar L; Bhargawa VL; Kumar S
Asia Oceania J Obstet Gynaecol; 1993 Jun; 19(2):133-40. PubMed ID: 7691050
[TBL] [Abstract][Full Text] [Related]
8. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
9. Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams University.
El-Lamie IK; Shehata NA; Abou-Loz SK; El-Lamie KI
Eur J Gynaecol Oncol; 2000; 21(6):605-9. PubMed ID: 11214621
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of 129 patients with advanced and recurrent malignant ovarian germ cell tumor].
Hong W; Zhang R; Liu L
Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):35-7. PubMed ID: 10682456
[TBL] [Abstract][Full Text] [Related]
11. Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
Terenziani M; Bisogno G; Boldrini R; Cecchetto G; Conte M; Boschetti L; De Pasquale MD; Biasoni D; Inserra A; Siracusa F; Basso ME; De Leonardis F; Di Pinto D; Barretta F; Spreafico F; D'Angelo P
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449306
[TBL] [Abstract][Full Text] [Related]
12. Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.
Dimopoulos MA; Papadimitriou C; Hamilos G; Efstathiou E; Vlahos G; Rodolakis A; Aravantinos G; Kalofonos H; Kouroussis C; Gika D; Skarlos D; Bamias A
Gynecol Oncol; 2004 Dec; 95(3):695-700. PubMed ID: 15581984
[TBL] [Abstract][Full Text] [Related]
13. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
[TBL] [Abstract][Full Text] [Related]
14. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
Gershenson DM; Morris M; Burke TW; Levenback C; Matthews CM; Wharton JT
Obstet Gynecol; 1996 Apr; 87(4):527-31. PubMed ID: 8602303
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
Li J; Yang W; Wu X
Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2015 Jun; 137(3):418-22. PubMed ID: 25842162
[TBL] [Abstract][Full Text] [Related]
17. Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary.
Carlson RW; Sikic BI; Turbow MM; Ballon SC
J Clin Oncol; 1983 Oct; 1(10):645-51. PubMed ID: 6199468
[TBL] [Abstract][Full Text] [Related]
18. Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamide.
Gershenson DM; Copeland LJ; Kavanagh JJ; Cangir A; Del Junco G; Saul PB; Stringer CA; Freedman RS; Edwards CL; Wharton JT
Cancer; 1985 Dec; 56(12):2756-61. PubMed ID: 2996746
[TBL] [Abstract][Full Text] [Related]
19. Nondysgerminomatous tumors of the ovary treated with cisplatin, vinblastine, and bleomycin: long-term results.
De Palo G; Zambetti M; Pilotti S; Rottoli L; Spatti G; Fontanelli R; Musumeci R; Kenda R; Bombardieri E; Stefanon B
Gynecol Oncol; 1992 Nov; 47(2):239-46. PubMed ID: 1281804
[TBL] [Abstract][Full Text] [Related]
20. High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy.
Pinkerton CR; Pritchard J; Spitz L
J Clin Oncol; 1986 Feb; 4(2):194-9. PubMed ID: 2418168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
